Charles Schwab Investment Advisory’s Novartis NVS Stock Holding History

Charles Schwab Investment Advisory’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,398,928	Closed	-$417M	–	122
2019 Q4	$417M	Buy	4,398,928 +96,711	+2%	+$8.68M	0.59%	40
2019 Q3	$374M	Buy	4,302,217 +73,039	+2%	+$6.56M	0.57%	46
2019 Q2	$386M	Sell	4,229,178 -357,934	-8%	-$30.3M	0.62%	37
2019 Q1	$395M	Buy	4,587,112 +74,209	+2%	+$5.96M	0.67%	34
2018 Q4	$347M	Buy	4,512,903 +44,659	+1%	+$3.48M	0.66%	39
2018 Q3	$345M	Buy	4,468,244 +72,532	+2%	+$5.36M	0.6%	45
2018 Q2	$298M	Buy	+4,395,712	New	+$303M	0.55%	51

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Charles Schwab Investment Advisory's NVS Position: Q1 2020 in Review

Charles Schwab Investment Advisory sold out of Novartis (NVS) in Q1 2020, closing a stake of 4,398,928 shares — an estimated $417M sold.

Charles Schwab Investment Advisory first reported a position in NVS in Q2 2018 and held it in 7 quarters. The position peaked at $417M in Q4 2019. 1,134 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

Charles Schwab Investment Advisory reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
Charles Schwab Investment Advisory sold 4,398,928 Novartis shares in Q1 2020, an estimated $417M.
Charles Schwab Investment Advisory first reported a position in Novartis in Q2 2018 and held it in 7 quarters.
Charles Schwab Investment Advisory's Novartis position peaked at $417M in Q4 2019.
1,134 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Charles Schwab Investment Advisory's 13F filing for Q1 2020, filed 15 May 2020.